Fig. 1.
Therapeutic efficacy of lenvatinib combined with PD-1 in patients with gallbladder cancer. A Maximum percentage change in the sum of the diameters of the target lesions from baseline. B Kaplan–Meier estimation of progression-free survival of the entire cohort. C Kaplan–Meier estimation of overall survival of the entire cohort